<DOC>
	<DOC>NCT02888262</DOC>
	<brief_summary>This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder</brief_summary>
	<brief_title>The Bipolar Illness Onset Study (the BIO Study)</brief_title>
	<detailed_description>The study will include 300 patients with newly diagnosed/first episode bipolar disorder, 200 healthy siblings or child family members and 100 healthy individuals without a family history of affective disorder. All individuals will be investigated with repeated blood tests, Smartphone recordings, neuropsychological tests and brain imaging during a five to ten year study period.</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>1. Newly diagnosed/first episode bipolar patients, 2. Firstgeneration relatives (siblings and children aged 15 to 40 years) to the recruited newly diagnosed/first episode bipolar patients. 3. Age and gender matched sample of healthy individuals without a firstgeneration family history of effective disorders 1. Significant physical disorders 2. Schizophrenia or related disorders</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Bipolar disorder</keyword>
	<keyword>Blood</keyword>
	<keyword>Smartphone</keyword>
	<keyword>Brain imaging</keyword>
	<keyword>Cognition</keyword>
	<keyword>Neuropsychology</keyword>
</DOC>